Novo Nordisk's Wegovy Weight Loss Shot Approved At Higher Dose in U.K.

Core Insights - The U.K. health regulator has approved a higher dose of Novo Nordisk's Wegovy weight-loss drug for patients with a body mass index (BMI) of at least 30 [1] Company Summary - Novo Nordisk's Wegovy is now available in a higher dosage, expanding its applicability to a broader range of patients [1]